Document

We consent to the reference to our firm under the caption “Experts” and to the use of our report dated March 21, 2024, in the Amendment No. 1 to the Registration Statement (Form S-1 No. 333-278393) and related Prospectus of LENZ Therapeutics, Inc. for the registration of 1,297,411 shares of its common stock.